Canadian application, no grantCanada
Anti-obesity polypeptides
CA 2444602 A1 · Owner: Yonsei University · Inventors: Lee, Dong-Kee; Hur, Man-Wook
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to anti-obesity polypeptides for restraining the generation of adipose tissue in vivo. The anti-obesity polypeptides can be used as obesity preventive vaccines or treating agents and in curing diabetes.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 19, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 19, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 19, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 19, 2002
GrantedNo grant recorded
Term endedApril 19, 2022
Patent numberCA 2444602 A1
Classification (IPC)C12N15/48 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.